Belantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment (Including Dialysis): Results From the Phase I DREAMM-12 Study

Article2024

P-395 Updated Results From DREAMM-3, a Phase 3 Study of Belantamab Mafodotin (Belamaf) Versus Pomalidomide Plus Dexamethasone in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM)

Vânia Hungria, Katja Weisel, Atanas Radinoff, Sosana Delimpasi, Gábor Mikala, Tamás Masszi, Jian Li, Marcelo Capra, Ângelo Maiolino, Vasiliki Pappa, Dominik Chraniuk, Iurii Osipov, Xavier Leleu, Michael Löw, Fotini M. Kouri, John Liboon, Chris Brawley, Eric Lewis, Gabriela Tubel, Mary Li, Astrid McKeown, Sumita Roy–Ghanta, Joanna Opalinska, Meletios A Dimopoulos

Article2023

Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The <scp>DARE</scp> study

Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis, Vasiliki Labropoulou, Sosana Delimpasi, Katia Mancuso, Elena Zamagni, Eirini Katodritou, Elena Rivolti, Marie‐Christine Kyrtsonis, Μαρία Ρούσσου, Despina Fotiou, Foteini Theodorakakou, Ioannis Ntanasis‐Stathopoulos, Evdoxia Hatjiharissi, Nikolaos Kanellias, Magdalini Migkou, Giorgos Cheliotis, Kyriaki Manousou, Maria Gavriatopoulou, Meletios A Dimopoulos

Article2020

Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study

Evangelos Terpos, Argiris Symeonidis, Sossana Delimpasi, Elena Zamagni, Eirini Katodritou, Elena Rivolti, Maria‐Christina Kyrtsonis, Despina Fotiou, Nikolaos Kanellias, Magdalini Migkou, Μαρία Ρούσσου, Maria Gavriatopoulou, E. Hatjiharissi, Michèle Cavo, Meletios A Dimopoulos

Article2020

Daratumumab with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment: Results on Efficacy and Safety of the Phase 2 Dare Study

Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis, Sosana Delimpasi, Michèle Cavo, Elena Zamagni, Eirini Katodritou, Elena Rivolti, Marie‐Christine Kyrtsonis, Maria Gavriatopoulou, Μαρία Ρούσσου, Despina Fotiou, Evdoxia Hatjiharissi, Nikolaos Kanellias, Magdalini Migkou, Meletios A Dimopoulos

Article2025

Characterization of Infections in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With Belantamab Mafodotin (Belamaf)–Based Regimens From the DREAMM-7 and DREAMM-8 Trials

Paweł Robak, Vânia Hungria, Luděk Pour, Kihyun Kım, Sergey Voloshin, Hanlon Sia, Esther González García, Chang‐Ki Min, Marcelo Pitombeira de Lacerda, Anna Sureda Balarí, Ivan Špıčka, Sosana Delimpasi, Marek Hus, Vera Zherebtsova, Christopher Wård, P. Joy Ho, Roman Hájek, Sebastian Grosicki, Kristin Morris, Maureen Nichols, Benga Kazeem, Elisabet E. Manasanch,

Discussion(0)

Related publications